TLR4 and inflammatory bowel disease: Mucosal immune disorders lead to IBD as a result of TLR4 activation results in NF‐κB activation and cytokine expression in macrophages.32 We investigated if lentinan inhibited lipopolysaccharide (LPS)‐stimulated TLR4 signalling and reduced IBD progression.